Get started
Author

Chu‐Pin Pai

Observed names: Chu-Pin Pai, ChuPin Pai
ORCID: 0000-0001-5732-7125
Observed ORCID: 0000-0001-5732-7125
OpenAlex ID: A5059655193
Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
2022 · Xing Gao, Ping-Chung Tsai, et al. · Cancers · 18
PDF
Clinical characteristics and risk factors for 30-day mortality in esophageal cancer patients with upper gastrointestinal bleeding: a multicenter study
2023 · Sz-Wei Lu, Chu-Pin Pai, et al. · Frontiers in Oncology · 12
PDF
Clinical outcome of patients after recurrent laryngeal nerve lymph node dissection for oesophageal squamous cell carcinoma
2021 · Chu-Pin Pai, Po-Kuei Hsu, et al. · Interactive Cardiovascular and Thoracic Surgery · 8
PDF
Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer
2023 · Chu-Pin Pai, Ling-I Chien, et al. · Cancers · 6
PDF
Novel Prediction Score for Arterial–Esophageal Fistula in Patients with Esophageal Cancer Bleeding: A Multicenter Study
2024 · Sz-Wei Lu, Kuang-Yu Niu, et al. · Cancers · 3
PDF
Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
2022 · Chu-Pin Pai, Ling-I Chien, et al. · Journal of Clinical Medicine · 3
PDF
De novo thymic carcinoma or malignant transformation: a myasthenic patient presented with multiple mediastinal tumours
2020 · Chu‐Pin Pai, Chih‐Ming Lin, et al. · Respirology Case Reports · 2
PDF
377. Neoadjuvant Carboplatin/paclitaxel Versus 5-fluorouracil/cisplatin in Combination With Radiotherapy for Esophageal Squamous Cell Carcinoma: a Multicenter Comparative Study
2022 · Xing Gao, PingChung Tsai, et al. · Diseases of the Esophagus
Works count: 8
Citation count: 52
H-index: 4
I10-index: 2
Year
Topic
Type